CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 147 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |
| SPHERA FUNDS MANAGEMENT LTD. | 180,000 | $4,953,600 | 0.90% |
| Bellevue Group AG | 1,900,000 | $52,288,000 | 0.84% |
| Eventide Asset Management | 1,600,000 | $44,032,000 | 0.79% |
| Sofinnova Investments, Inc. | 424,259 | $11,675,608 | 0.74% |
| Mirador Capital Partners LP | 107,818 | $2,967,151 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $2,752,000 | 0.50% |
| Polar Capital Holdings Plc | 2,426,756 | $66,784,325 | 0.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 48,099 | $1,322,242 | 0.44% |
| Rock Springs Capital Management LP | 500,101 | $13,762,780 | 0.37% |
| Sofinnova Investments, Inc. | 200,000 | $5,504,000 | 0.35% |
External links
This page lists CELLDEX THERAPEUTICS INC NEW's shareholders in Q3 2023. To view CELLDEX THERAPEUTICS INC NEW's shareholder history, click here.